These observations are further supported by data obtained in humans, where the liver accumulation of CD8+ Trm cells parallels the severity of the disease, suggesting a possible role of these cells in regulating NASH progression [106]. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.